This is the hover veil
Menu
Menu
Home
Living
guidelines
Clinical
flowcharts
Evidence
under review
Do you have a clinical question?
About the taskforce
About the guidelines
FAQs
News
Contact us
About the taskforce
About the guidelines
FAQs
News
Contact us
News
News
Communique
Video
Explainer
Media release
Topics
ACEM
ALEC
Allied Health Professions Australia
Antenatal corticosteroids
Anticoagulation
ANZ Guidelines
ANZICS
ANZJOG
Aprepitant
ARC
ASCOT
ASID
Australasian Sleep Association
Azithromycin
Bamlanivimab
Bamlanivimab plus etesevimab
Baricitinib
Basic Life Support
Bromhexine hydrochloride
Burnet
Cardiac arrest
CHF
Children and adolescents
CMCS
Cochrane
Colchicine
Consumer Panel
Convalescent plasma
Corticosteroids
COVID-19 COS
CPR
Delayed umbilical cord clamping
Dexamethasone
Disease-modifying treatments
Dutasteride
Enisamium
Extracorporeal membrane oxygenation
Flowchart
GPs
HCW
High-flow nasal oxygen
Hydroxychloroquine
Ian Potter Foundation
ICEG
Interferon Gamma
Interferon β-1a (inhaled)
Intravenous immunoglobulin
IPC
IPC Panel
Ivermectin
Long COVID
Monoclonal antibody therapy
N-acetylcysteine
NHMRC
NPS MedicineWise
Oestrogen containing therapies
Palliative Care
Peginterferon lambda
PIMS-TS
Podcast
Post-viral symptoms
Pregnancy and perinatal care
Pregnant & Postpartum women
Prone positioning
Prone positioning for adults (non-ventilated)
RANZCOG
RCTs
RECOVERY Trial
Regeneron
REGN-COV2
REMAP-CAP
Remdesivir
Respiratory
Respiratory management
Respiratory support
Royal Australian College of Surgeons
Sarilumab
Sofosbuvir plus daclatasvir
Telmisartan
Tocilizumab
Tociluzimab
Treatment
TSANZ
Umifenovir
Vitamin C
Vitamin D
VTE prophylaxis
Zinc
Featured
Women who lead: Sutapa Mukherjee and her journey to the Taskforce
8 March, 2021
As the female co-chair of the Taskforce Guidelines Leadership Group, the contribution of Associate Professor Sutapa Mukherjee in the fight against COVID-19 is reason enough to be recognised...
COVID-19 Research Pipeline
STUDIES
Cochrane COVID-19 Study Register
52,228
Registered/ Published
RCT
s
covid-nma.com
2,731
Registered
235
Published
SYSTEMATIC REVIEWS
Prospero
3,673
Registered
As at 1 April 2021
Tweets by evidenceCOVID19
FILTERED BY > Azithromycin
Clear filter
Guidelines update, version 34.1
18 February, 2021
Updates to the Australian guidelines for the clinical care of people with COVID-19 this week include: Dutasteride - preprint publication status has been removed from the summary information to reflect publication of the included trial by Cadegiani et al. The time to recovery data and number of included patients has been updated with no change to strength or direction of...
News
Communique # 37
29 January, 2021
Following a well-earned break, the Taskforce team has now returned to full capacity. Global evidence surveillance continued throughout January, with six clinical panel meetings held since January 11....
Communique
Weekly Communique # 24
24 September, 2020
WEEK IN REVIEW Six-month milestone for the Taskforce There was great anxiety among clinicians back in March, as Australia prepared to face the first wave of the COVID-19 pandemic and the...
Communique
